Navigation Links
Radiologists use special MRI to identify brain cancer early
Date:3/24/2008

OAK BROOK, Ill. A special type of magnetic resonance imaging (MRI) can depict changes in blood volume in the brain that often precede cancerous transformation of brain tumors, according to a new study published in the April issue of the journal Radiology.

We found that increases in blood volume within the tumor measured noninvasively by perfusion MRI precede other markers of malignant transformation by a year or more, said study co-author Adam Waldman, Ph.D., M.R.C.P., F.R.C.R., consultant neuroradiologist and imaging research director at Imperial College NHS Trust and honorary senior lecturer at Imperial College and University College, London.

Low-grade gliomas are primary brain tumors that grow slowly over several years. Eventually, almost all low-grade gliomas progress to high-grade gliomas, which carry a poor prognosis.

Patients with low-grade gliomas are often young and may remain clinically well for many years but, at an unpredictable time their tumor will transform to an aggressively high-grade glioma, Dr. Waldman said.

For the study, the researchers performed perfusion MRI on 13 patients with low-grade gliomas to determine whether relative cerebral blood volume (rCBV) changes are an indicator of future malignant transformation.

Brain tumors can bring about the formation of new blood vessels, a process known as angiogenesis. These vessels are abnormal and lead to changes in blood volume and flow. Using perfusion MRI, radiologists can detect these changes well before they become apparent on contrast-enhanced MR images.

The patients underwent perfusion MRI and contrast-enhanced MRI every six months for up to three years. Seven patients progressed to high-grade, malignant gliomas between six and 36 months. In the six patients whose disease remained stable, rCBV remained relatively stable, increasing from a mean level of 1.31 at the beginning of the study to 1.52 over the follow-up period. However, in the patients exhibiting tumor transformation, mean rCBV increased progressively from 1.94 at study entry to 3.14 twelve months prior to transformation, to 3.65 six months prior to transformation and to 5.36 at the time transformation was diagnosed.

These findings suggest that significant changes in rCBV represent an important marker of malignant change in gliomas and reflect the earliest stages of the transformation process. Further, the data support the likelihood that the cellular processes underlying malignant transformation may occur 12 months or more before visible on contrast MRI.

We have shown that perfusion MRI provides a noninvasive means of assessing the risk of transformation in individual patients, Dr. Waldman said. Increasing perfusion can be regarded as an early warning sign of impending malignant transformation that can assist radiologists in identifying those patients most likely to benefit from earlier or more aggressive treatment.


'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Related medicine news :

1. Illinois Radiologists Self-Edit Reports, Reduce Turnaround Time with SpeechQ for Radiology(TM)
2. Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise
3. Radiologists identify early brain marker of Alzheimers disease
4. Incidental findings found when radiologists take a broader look at renal MRA
5. Gorilla Receives State-Of-The-Art Treatment for Uterine Fibroids from Interventional Radiologists
6. Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas
7. Radiologists encouraged to look beyond cancer for clinically unseen diseases
8. Bernard A. Krooks From the Special Needs Alliance to Talk Tax Strategies for Individuals With Disabilities Tomorrow on Good Morning America NOW
9. Deerfield Spa, Voted Among Best Affordable Spas, Opens 2008 Season With Discounts, Savings, Gifts, Specials
10. Goosie Cards to Support Autism Awareness Month With Special Discount Program
11. SearchMedica Offers Medical Professionals Six New Specialized Clinical Web Searches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... , ... May 06, 2016 , ... ... AsedaSciences® in an upcoming episode, airing third quarter 2016, via Discovery Channel. Dates ... of becoming a leader in optimized drug discovery through innovative cellular analysis. In ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... does to reduce fat areas around the body, is the most popular among ... results just released make perfect sense to cosmetic surgeon Dr. Richard Buckley, medical ...
(Date:5/6/2016)... Grants Pass, OR (PRWEB) , ... May 06, 2016 , ... ... the eyes. In other seasons, when the weather is too cold, dry or hot, ... weather, the eyes can actually absorb moisture from the surrounding air. There’s only one ...
(Date:5/6/2016)... ... May 06, 2016 , ... Online HR/benefits platforms offer a range ... game for traditional brokers and health plans. “ The Rapid Emergence of Online Benefits ... Atlantic Information Services, Inc. (AIS), will offer an accurate picture of online benefits today, ...
(Date:5/6/2016)... ... May 06, 2016 , ... From May 4 to 6, ... members the unique opportunity to learn more about Signia’s technology and the successful business ... “It is our priority to see practices succeed in this highly competitive industry,” said ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... , May 6, 2016 ... of liver disorders along with rise in obesity ... drugs in the coming few years. The NASH ... last five years on account of rising number ... is a large, un-tapped market with no FDA ...
(Date:5/5/2016)... -- Replikins Ltd. today reported initial promising results in animal trials of its Zika vaccine ... ... ... ... on Pubmed. The analysis identified the highest gene Replikin Counts in Zika history back ...
(Date:5/5/2016)...  Endo International plc (NASDAQ: ENDP ... Lortie , President, U.S. Branded Pharmaceuticals, has decided ... appointment of a successor. Mr. Lortie joined Endo ... with responsibility for all strategic, commercial and operational ... development, commercial operations, managed markets, manufacturing, supply chain ...
Breaking Medicine Technology: